Sacral Neuromodulation for Refractory Overactive Bladder, Interstitial Cystitis, and Painful Bladder Syndrome

被引：24

作者：

Laviana, Aaron ^{[1
]}

Jellison, Forrest ^{[1
]}

Kim, Ja-Hong ^{[1
]}

机构：

[1] UCLA Sch Med, Dept Urol, Div Pelv Med & Reconstruct Surg, Los Angeles, CA 90095 USA

来源：

NEUROSURGERY CLINICS OF NORTH AMERICA | 2014年 / 25卷 / 01期

关键词：

Sacral neuromodulation; Overactive bladder; Interstitial cystitis; Painful bladder syndrome; Urinary urge incontinence; Pelvic floor disorders; Chronic pelvic pain; QUALITY-OF-LIFE; URINARY-TRACT SYMPTOMS; NERVE-STIMULATION; VOIDING DYSFUNCTION; URGE INCONTINENCE; DOUBLE-BLIND; ROOT NEUROMODULATION; EFFICACY; ONABOTULINUMTOXINA; MANAGEMENT;

D O I：

10.1016/j.nec.2013.08.001

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Various pelvic floor conditions, including overactive bladder syndrome and chronic pelvic pain, have been successfully managed with the neuromodulation of sacral nerves. Sacral neuromodulation is a minimally invasive procedure involving the implantation of a programmable pulse generator that delivers low-amplitude electrical current via quadripolar tined leads through the S3 foramen. Durable efficacy has been demonstrated in retrospective studies, but questions regarding ideal patient candidacy and optimal technical considerations remain unanswered.

引用

页码：33 / +

页数：15

共 93 条

[1] Sacral neuromodulation: Cost considerations and clinical benefits [J].

Aboself, Sherif R. ;

Kim, Dennis H. ;

Rieder, Jocelyn M. ;

Rhee, Eugene Y. ;

Menefee, Shawn A. ;

Kaswick, Julie R. ;

Ree, Michael H. .

UROLOGY, 2007, 70 (06) :1069-1073

[2] Urgency: the key to defining the overactive bladder [J].

Abrams, P .

BJU INTERNATIONAL, 2005, 96 :1-3

[3]

Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052

[4]

Abrams P, 2000, AM J MANAG CARE, V6, pS580

[5] Outcomes of Intravesical Botulinum Toxin for Idiopathic Overactive Bladder Symptoms: A Systematic Review of the Literature [J].

Anger, Jennifer T. ;

Weinberg, Aviva ;

Suttorp, Marika J. ;

Litwin, Mark S. ;

Shekelle, Paul G. .

JOURNAL OF UROLOGY, 2010, 183 (06) :2258-2264

[6] Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity [J].

Apostolidis, A ;

Popat, R ;

Yiangou, Y ;

Cockayne, D ;

Ford, APDW ;

Davis, JB ;

Dasgupta, P ;

Fowler, CJ ;

Anand, P .

JOURNAL OF UROLOGY, 2005, 174 (03) :977-982

[7] Sacral neuromodulation and refractory overactive bladder: an emerging tool for an old problem [J].

Banakhar, Mai Ahmed ;

Al-Shaiji, Tariq ;

Hassouna, Magdy .

THERAPEUTIC ADVANCES IN UROLOGY, 2012, 4 (04) :179-185

[8] Contrasting the percutaneous nerve evaluation versus staged implantation in sacral neuromodulation [J].

Baxter C. ;

Kim J.-H. .

Current Urology Reports, 2010, 11 (5) :310-314

[9]

Berry S, 2009, AM UR ASS ANN M CHIC

[10] An update on sacral neuromodulation: where do we stand with this in the management of lower urinary tract dysfunction in 2010? [J].

Bosch, J. L. H. Ruud .

BJU INTERNATIONAL, 2010, 106 (10) :1432-1442

← 1 2 3 4 5 6 7 8 9 10 →